Previously, aberrantly high expression of PSMA5 has been detected in prostate cancer,24 lung adenocarcinoma (LUAD),25 pulmonary neuroendocrine tumors,26 and endometrial cancer,27 hinting its associations with progression of above cancers.25 Here, PSMA5 is linked to prostate cancer.